Anchiano Therapeutics Ltd. (“Anchiano”) (Nasdaq: ANCN), a preclinical biopharmaceutical company, and Chemomab Ltd. (“Chemomab”), a...

Biosight Ltd., a pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders,...

Nov. 12th 2020 D-Fend Solutions has opened its first North American office in McLean, Virginia, to expand its operations and meet the...

9 December 2020 – Alstom has finalised a deal to invest US$7 million in Cylus, an Israel-based cybersecurity specialist, thus acquiring a...

BiomX Announces Preclinical Results of Analysis of Patient Samples and Engineering of Phage for Therapeutic Applications in Colorectal...